Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

New Insights into Tolytoxin Effect in Human Cancer Cells: Apoptosis Induction and the Relevance of Hydroxyl Substitution of Its Macrolide Cycle on Compound Potency

K. Delawská, P. Divoká, D. Sedlák, M. Kuzma, K. Saurav, M. Macho, G. Steinbach, P. Hrouzek

. 2022 ; 23 (1) : e202100489. [pub] 20211209

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
21-05649K Czech Grant Agency (Discovery of promising chemotherapeutic candidates in cyanobacteria
68378050-KAV-NPUI Ministry of Education, Youth and Sports of the Czech Republic
LM2018130 National infrastructure for chemical biology
41 Cross-Border cooperation Czech-Bavaria
GINOP-2.3.2-15-2016-00001 Cross-Border cooperation Czech-Bavaria
Medical University Innsbruck

Scytophycins, including tolytoxin, represent a class of actin disrupting macrolides with strong antiproliferative effects on human cells. Despite intense research, little attention has been paid to scytophycin-induced cell death or the structural features affecting its potency. We show that tolytoxin and its natural analogue, 7-O-methylscytophycin B, lacking the hydroxyl substitution in its macrolactone ring, differ substantially in their cytotoxic effect. Both compounds increase the level of caspases 3/7, which are the main executioner proteases during apoptosis, in HeLa wild-type (WT) cells. However, no caspase activity was detected in HeLa cells lacking Bax/Bak proteins crucial for caspase activation via the mitochondrial pathway. Obtained data strongly suggests that scytophycins are capable of inducing mitochondria-dependent apoptosis. These findings encourage further research in structure-activity relationships in scytophycins and highlight the potential of these compounds in targeted drug delivery.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011384
003      
CZ-PrNML
005      
20220506130320.0
007      
ta
008      
220425s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cbic.202100489 $2 doi
035    __
$a (PubMed)34821450
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Delawská, Kateřina $u Institute of Microbiology of the Czech Academy of Sciences - Center Algatech, Novohradska 237, 37981, Trebon, Czech Republic $u Faculty of Science, University of South Bohemia in České Budějovice, Branišovská 1760, 37005, České Budějovice, Czech Republic
245    10
$a New Insights into Tolytoxin Effect in Human Cancer Cells: Apoptosis Induction and the Relevance of Hydroxyl Substitution of Its Macrolide Cycle on Compound Potency / $c K. Delawská, P. Divoká, D. Sedlák, M. Kuzma, K. Saurav, M. Macho, G. Steinbach, P. Hrouzek
520    9_
$a Scytophycins, including tolytoxin, represent a class of actin disrupting macrolides with strong antiproliferative effects on human cells. Despite intense research, little attention has been paid to scytophycin-induced cell death or the structural features affecting its potency. We show that tolytoxin and its natural analogue, 7-O-methylscytophycin B, lacking the hydroxyl substitution in its macrolactone ring, differ substantially in their cytotoxic effect. Both compounds increase the level of caspases 3/7, which are the main executioner proteases during apoptosis, in HeLa wild-type (WT) cells. However, no caspase activity was detected in HeLa cells lacking Bax/Bak proteins crucial for caspase activation via the mitochondrial pathway. Obtained data strongly suggests that scytophycins are capable of inducing mitochondria-dependent apoptosis. These findings encourage further research in structure-activity relationships in scytophycins and highlight the potential of these compounds in targeted drug delivery.
650    _2
$a protinádorové látky $x chemie $x farmakologie $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a lidé $7 D006801
650    _2
$a hydroxidy $x chemie $x farmakologie $7 D006878
650    _2
$a makrolidy $x chemie $x farmakologie $7 D018942
650    _2
$a mitochondrie $x účinky léků $x metabolismus $7 D008928
650    _2
$a pyrany $x chemie $x farmakologie $7 D011714
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Divoká, Petra $u Institute of Microbiology of the Czech Academy of Sciences - Center Algatech, Novohradska 237, 37981, Trebon, Czech Republic
700    1_
$a Sedlák, David $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., 142 20, Prague 4, Czech Republic
700    1_
$a Kuzma, Marek $u Laboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague, Czech Republic
700    1_
$a Saurav, Kumar $u Institute of Microbiology of the Czech Academy of Sciences - Center Algatech, Novohradska 237, 37981, Trebon, Czech Republic
700    1_
$a Macho, Markéta $u Institute of Microbiology of the Czech Academy of Sciences - Center Algatech, Novohradska 237, 37981, Trebon, Czech Republic $u Faculty of Science, University of South Bohemia in České Budějovice, Branišovská 1760, 37005, České Budějovice, Czech Republic
700    1_
$a Steinbach, Gabor $u Institute of Biophysics, Biological Research Center, 6726, Temesvári krt. 62., Szeged, Hungary
700    1_
$a Hrouzek, Pavel $u Institute of Microbiology of the Czech Academy of Sciences - Center Algatech, Novohradska 237, 37981, Trebon, Czech Republic $1 https://orcid.org/0000000220610266
773    0_
$w MED00006594 $t Chembiochem : a European journal of chemical biology $x 1439-7633 $g Roč. 23, č. 1 (2022), s. e202100489
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34821450 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130312 $b ABA008
999    __
$a ok $b bmc $g 1789125 $s 1162582
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 23 $c 1 $d e202100489 $e 20211209 $i 1439-7633 $m Chembiochem $n Chembiochem $x MED00006594
GRA    __
$a 21-05649K $p Czech Grant Agency (Discovery of promising chemotherapeutic candidates in cyanobacteria
GRA    __
$a 68378050-KAV-NPUI $p Ministry of Education, Youth and Sports of the Czech Republic
GRA    __
$a LM2018130 $p National infrastructure for chemical biology
GRA    __
$a 41 $p Cross-Border cooperation Czech-Bavaria
GRA    __
$a GINOP-2.3.2-15-2016-00001 $p Cross-Border cooperation Czech-Bavaria
GRA    __
$p Medical University Innsbruck
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...